NANKAI CHEMICAL COMPANY,LIMITED FY2026 Q3 Earnings Report

Financial Highlights

• Net Sales: ¥14.80B
• Operating Income: ¥1.04B
• Net Income: ¥2.39B
• EPS: ¥1,179.90

Income Statement

Balance Sheet

Profitability Ratios

Year-over-Year Comparison

Share Information

Dividend Information

Full Year Forecast

---

AI Financial Analysis

Executive Summary

Verdict: FY2026 Q3 consolidated results show firm operating performance but materially distorted net income due to a large one-time gain. Revenue grew modestly to ¥14,799 (100M JPY) (+1.0% YoY) and operating income rose to ¥103.6 (100M JPY) (+6.8% YoY), reflecting slight margin improvement from core operations. Gross profit was ¥422.6 (100M JPY) (gross margin 28.6%) while SG&A totaled ¥318.9 (100M JPY), leaving operating income at ¥103.6 (100M JPY) (EBIT margin ~7.0%). Ordinary income was ¥107.2 (100M JPY), down 3.9% YoY. Net income attributable to owners jumped to ¥238.6 (100M JPY) (+205.3% YoY) driven almost entirely by an extraordinary gain on sale of fixed assets of ¥251.9 (100M JPY). Excluding that gain, recurring profitability is far more modest. Calculated DuPont ROE stands at 22.1% (Net margin 16.1% × Asset turnover 0.713 × Financial leverage 1.92x), but the high net margin is inflated by the one-time gain. Effective tax rate on recurring profit is 30.6%. Cash & liquidity appear healthy on the balance sheet: current ratio 170.0% and quick ratio 147.8%, with cash & deposits of ¥21.21 (100M JPY). Interest-bearing debt is ¥25.41 (100M JPY) and D/E ~0.92x; interest coverage is strong at 21.6x. Working capital dynamics are concerning: accounts receivable rose sharply to ¥54.83 (100M JPY) (+37.5% YoY) and receivable days (DSO) are high at 135 days, while inventory days are 103 days, producing a long cash conversion cycle of 143 days. Several balance sheet movements are notable: PPE decreased by 28.3% YoY (¥109.59 → ¥78.54 (100M JPY)), short-term loans fell 41.2% and retained earnings increased materially due to the extraordinary gain. Earnings quality flags are significant: one-time items (gain on sale of fixed assets) exceed reported net income (one‑time items = 110.3% of net income), which means recurring cash earnings are substantially lower than reported NI. The company’s full-year forecast (Net income ¥22.0 (100M JPY), DPS ¥35) implies management expects the extraordinary gain to be non-recurring and forecasts lower full-year net income than the year-to-date cumulative reported NI, indicating Q3 items distort comparability. Operationally the chemical/various-salt segments show stable top-line contribution (segment sales ¥12,630 and ¥2,168 (100M JPY) respectively) and segment profit rose to ¥103.6 (100M JPY) at consolidated level. The impairment recorded in the period is small (¥0.04 (100M JPY)); segment notes show impairment charges of ¥0.21 (100M JPY) in the prior comparative period and ¥0.04 in the current. Forward-looking implications: investors should treat ROE and net margin metrics with caution until recurring net income and operating cash flow are observed; monitor collection of receivables and inventory reductions to restore a healthier CCC; watch for reinvestment or deleveraging of proceeds from fixed-asset sale given the PPE decline; dividend guidance (DPS ¥35) appears modest relative to reported NI but is supported by management forecast and ample liquidity. In summary: solid operational margin improvements but material one-time accounting items and working capital deterioration weaken the quality of earnings and cash conversion, so forward earnings sustainability depends on receivables/inventory normalization and absence of further one-offs.

Profitability Analysis

dupont_3_factor:

• net_profit_margin: 16.1% (Calculated from Net Income / Revenue; inflated by extraordinary gain)
• asset_turnover: 0.713 (Revenue / Total Assets)
• financial_leverage: 1.92x (Total Assets / Equity)
• calculated_roe: 22.1% (matches reported ROE) which_component_changed_most: Net profit margin increased sharply YoY but this change is driven almost entirely by a one-time extraordinary gain (Gain on sale of fixed assets ¥251.9 (100M JPY)), not by recurring operating improvement. business_reason_for_change: Extraordinary gain on sale of fixed assets booked in the period inflated net income; recurring operating income rose only modestly (+6.8% YoY), while asset base fell (PPE -28.3%), mechanically lifting ROE via asset contraction and the one-off profit. sustainability_assessment: The net margin expansion is not sustainable — it's driven by non-recurring gains. Asset turnover and leverage are within reasonable ranges for a manufacturing/chemical business, but receivable and inventory increases weigh on operating cash conversion. The recurring operating margin (~7.0% EBIT margin) is the sustainable baseline. concerning_trends: Working capital pressure: SG&A growth is modest but accounts receivable increased +37.5% YoY while sales rose only 1.0% — this suggests deterioration in collection efficiency (DSO flagged high). Inventory days are high (103 days). These indicate operating leverage risks and potential earnings quality deterioration if provisions or bad debt crystallize.

Growth Assessment

revenue_sustainability: Top-line growth is modest: revenue ¥14,799 (100M JPY) +1.0% YoY. Segment disclosures show stable sales across the chemical and salt businesses but no strong accelerating demand drivers reported. profit_quality: Operating income improved to ¥103.6 (100M JPY) (+6.8% YoY) — a positive sign — but net income of ¥238.6 (100M JPY) is dominated by an extraordinary gain (¥251.9 (100M JPY)). One-time items account for 110.3% of net income; recurring profit is materially lower than reported net income. outlook: Management's full-year forecast (Net income ¥220 (100M JPY), Operating income ¥180 (100M JPY), DPS ¥35) implies the extraordinary gain will not recur and that recurring earnings will normalize below the YTD reported net income. Key risks to growth are slow working capital turnover and limited topline momentum.

Financial Health

liquidity:

• current_ratio: 170.0% (Current Assets ¥110.59 vs Current Liabilities ¥65.07 (100M JPY)) — healthy
• quick_ratio: 147.8% — healthy
• cash_and_deposits: ¥21.21 (100M JPY) solvency:
• debt_to_equity: 0.92x (Interest-bearing debt ¥25.41 / Equity ¥27.52? — reported as 0.92x) — within conservative range
• debt_capital_ratio: 19.0% — conservative
• interest_coverage: 21.58x — strong maturity_mismatch_risk: Short-term loans decreased materially YoY (¥8.50 → ¥5.00 (100M JPY), -41.2%), current portion of long-term loans remains (¥8.30 (100M JPY) current portion in raw data), cash/short-term debt is 4.24x — short-term liquidity appears adequate. However, the sharp decrease in short-term borrowings may reflect repayment funded by asset disposals; monitor reliance on asset sales for liquidity. off_balance_sheet: No off-balance sheet obligations disclosed in available data. notable_bs_changes: Short-term Loans: -¥3.50 (100M JPY) (-41.2%) - reduced short-term borrowing, improves liquidity ratios but may reflect use of sale proceeds; monitor refinancing needs., Accounts Receivable: +¥15.0 (100M JPY) (+37.5%) - substantial increase in receivables relative to sales growth, raises collection risk and drives high DSO., Property, Plant & Equipment (PPE): -¥31.05 (100M JPY) (-28.3%) - large reduction due to disposals (offset by extraordinary gain), lowers asset base and may reduce future production capacity or signal asset rationalization., Retained Earnings: +¥22.55 (100M JPY) (+26.2%) - increase driven by the extraordinary gain boosting equity; sustainable only if recurring earnings support it.

Notable B/S Changes

Short-term Loans: -¥3.50 (100M JPY) (-41.2%) - Significant reduction in short-term borrowings. Business implication: improves current liquidity ratios but may reflect repayment funded by asset disposals; monitor refinancing needs. Accounts Receivable: +¥15.0 (100M JPY) (+37.5%) - Large increase in receivables despite only 1% revenue growth. Business implication: deterioration in collection efficiency; increases credit and liquidity risk and is primary driver of very high DSO. Property, Plant & Equipment (PPE): -¥31.05 (100M JPY) (-28.3%) - Material decrease due to disposals (gain on sale of fixed assets). Business implication: lowers asset base and depreciation, temporarily boosts equity via gain but could indicate capacity rationalization or one-off monetization of assets; watch for impact on future production capability. Retained Earnings: +¥22.55 (100M JPY) (+26.2%) - Increase largely due to the extraordinary gain. Business implication: equity strengthened by non-recurring item; sustainability depends on recurring profitability.

Cash Flow Quality

earnings_quality: Cannot calculate OCF/Net Income (OCF not disclosed). However, indicators point to low cash quality of the reported net income because net income is driven by non-cash/one-time sale gains and working capital has deteriorated (DSO/DIO high). ocf_net_income_flag: OCF/Net Income not reported; treat reported NI with caution given one-time items >100% of NI. fcf_sustainability: Free cash flow not reported. Given high receivable and inventory days and the one-time nature of the asset sale, sustainable FCF generation from operations is uncertain until receivables/inventory normalize. working_capital_signs_of_manipulation: Accounts receivable growth (+37.5% YoY) and inventory rise with only 1% revenue growth suggest collection or recognition timing issues — could be operational or timing-related rather than intentional manipulation, but it materially weakens near-term cash conversion.

Dividend Sustainability

dps_and_payout: Interim DPS Q2 ¥20.0 and Year-end DPS guidance ¥35.0 (annual ¥55.0). Calculated payout ratio is ~5.4% based on the methodology provided (using reported net income), though that low payout ratio is driven by the large one-time gain inflating net income. fcf_coverage: FCF coverage not calculable (FCF not reported). Given working capital strain and PPE reduction financed by asset sales, sustainability of the DPS depends on recurring operating cash generation rather than one-off proceeds. policy_outlook: Management maintained DPS policy at ¥35 year-end (and ¥20 interim). Given forecasted full-year net income of ¥220 (100M JPY) (below YTD cumulative NI), dividends appear set based on a more conservative recurring profit view — this implies management is not using the full gain to materially raise dividends beyond guidance.

Risk Assessment

Business risks include Working capital risk: Very high DSO (135 days) and high DIO (103 days) increase liquidity and counterparty credit risk., Demand risk: Revenue growth is muted (+1.0% YoY), exposing the company to market cyclicality in chemicals/salts., Operational risk: PPE reduction (-28.3% YoY) may indicate disposal of productive assets or capacity rationalization; potential capacity constraints or cost impacts could follow..

Financial risks include Earnings quality risk: One-time items (gain on sale of fixed assets ¥251.9) exceed reported net income, indicating material volatility and low recurrence., Receivable concentration/credit risk: Large rise in receivables without corresponding revenue growth increases default exposure., Refinancing risk: Short-term loans decreased materially; if asset sale proceeds financed repayment, future refinancing needs should be monitored..

Key concerns include High one-time items: Quality Alert HIGH_ONE_TIME_ITEMS (110.3% of net income) — root cause is gain on sale of fixed assets; typical for the industry when assets are rationalized but not improving recurring earnings; impact: inflates profitability metrics and ROE, masking true operating performance., Working capital deterioration: Quality Alerts HIGH_RECEIVABLE_DAYS, HIGH_INVENTORY_DAYS, LONG_CCC — root cause likely slower collections and higher inventory levels; impact: strains cash conversion and raises the potential need for external financing if not corrected., Asset base contraction: PPE -28.3% — root cause likely asset disposals; impact: may reduce future capacity and capital expenditure needs but also implies one-off gains and potential reduction in depreciation shield..

Investment Implications

Key takeaways include Reported net income is not representative of recurring earnings due to a large gain on sale of fixed assets (¥251.9 (100M JPY))., Operating performance is steady: revenue +1.0% and operating income +6.8% YoY, but recurring margins (~7.0% EBIT margin) are modest., ROE is high (22.1%) but driven by one-offs and asset base reduction; treat as transitory until recurring cash earnings confirm sustainability., Working capital is a material near-term weakness: DSO 135 days, DIO 103 days, CCC 143 days — monitor AR collections and inventory turns., Balance sheet liquidity is adequate today (current ratio 170%, cash/short-term debt 4.24x), but reliance on asset disposals to improve metrics is a risk if repeated..

Metrics to watch include Operating cash flow and OCF / Net Income ratio (to confirm earnings quality)., Receivable days (DSO) and inventory days (DIO) — targets to reduce toward industry benchmarks., Recurring operating income and ordinary income excluding one-time gains (compare to management full-year forecast)., CapEx and PPE trends after disposals — whether the company reinvests or shrinks capacity., Dividend guidance vs reported FCF once OCF is disclosed..

Regarding relative positioning, Relative to peers in specialty chemicals/industrial salts, the company shows conservative leverage and strong interest coverage, but it has weaker working capital management and a temporarily inflated ROE. If receivables/inventory normalize and management demonstrates recurring cash flow, the company could be classed as operationally stable with conservative balance sheet metrics; until then it should be treated as higher earnings-volatility risk within its sector.